Machaon Medical Evaluations Mount Pleasant, SC - 29464

Machaon Medical Evaluations is categorized under Health Services in Mount Pleasant, SC and active since 2011.

Machaon Medical Evaluations was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact James Moriarty at the company’s single location by writing to 300 West Coleman Boulevard, Mount Pleasant, South Carolina SC 29464 or by phoning (843) 606-9313. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Machaon Medical Evaluations
Contact Person: James Moriarty
Address: 300 West Coleman Boulevard, Mount Pleasant, South Carolina 29464
Phone Number: (843) 606-9313
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 6214930
Share This Business:

Machaon Medical Evaluations was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact James Moriarty for inquiries that concern Machaon Medical Evaluations by calling the company number (843) 606-9313, as your correspondence is most welcome. Additionally, the physical location of the single location of Machaon Medical Evaluations can be found at the coordinates 32.797527,-79.89066 as well as the street address 300 West Coleman Boulevard in Mount Pleasant, South Carolina 29464.

For its online presence, you may visit Machaon Medical Evaluations’s website at and engage with its social media outlets through on Twitter and on Facebook.